Preoperative inflammatory biomarkers analysis in prognosis of systemic inflammatory response syndrome following percutaneous nephrolithotomy: A systematic review and meta-analysis.

IF 1.3 Q3 UROLOGY & NEPHROLOGY
Dwi Evan Prima Putra Noviardi, Zuhirman, Indra Jaya, Afdal, Joko Pitoyo, Muhammad A Yashar, Nathanael Ibot David
{"title":"Preoperative inflammatory biomarkers analysis in prognosis of systemic inflammatory response syndrome following percutaneous nephrolithotomy: A systematic review and meta-analysis.","authors":"Dwi Evan Prima Putra Noviardi,&nbsp;Zuhirman,&nbsp;Indra Jaya,&nbsp;Afdal,&nbsp;Joko Pitoyo,&nbsp;Muhammad A Yashar,&nbsp;Nathanael Ibot David","doi":"10.1080/2090598X.2022.2138891","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Urosepsis is one of the most serious complications of percutaneous nephrolithotomy (PCNL). To date, many studies aim to prescreen urosepsis possibility after PCNL through blood components. This meta-analysis aims to determine C-reactive protein (CRP), neutrophil to lymphocyte ratio (NLR), and platelet to lymphocyte ratio (PLR) obtained preoperatively used to predict postoperative sepsis after PCNL.</p><p><strong>Methods: </strong>A comprehensive literature search was performed through the electronic databases in March 2022. The quality of the included studies was assessed with Newcastle Ottawa Scale (NOS), while the presence of publication bias was assessed using Begg's and Egger's tests. Quantitative analysis was performed using RevMan 5.4 and Comprehensive Meta-Analysis 3.0. The outcome of interest is the difference in blood component count between groups that experienced systemic inflammatory response syndrome (SIRS) and those who did not. Acquired data were pooled as mean difference (MD).</p><p><strong>Results: </strong>Total of 11 studies were included in the quantitative analysis. Leukocyte count showed an increase between the group that experienced SIRS and those who were not (MD 0.69, 95% confidence interval [CI] 0.48 to 0.91, <i>p</i> < 0.00001). Similar result was also found in other analysis, CRP (MD 3.30, 95% [CI] 2.33 to 4.26, <i>p</i> < 0.00001), NLR (MD 0.59, 95% [CI] 0.48 to 0.69, <i>p</i> < 0.00001), and PLR (MD 23.40, 95% [CI] 17.98 to 28.82, <i>p</i> < 0.00001).</p><p><strong>Conclusion: </strong>Preoperative PLR, NLR, and CRP had significant association with postoperative sepsis after PCNL. It is beneficial for urologists to ensure close monitoring of these biomarkers levels before PCNL. The result of this study might serve as a consideration for future clinical approaches in determining beneficial treatment for urolithiasis patients.</p>","PeriodicalId":8113,"journal":{"name":"Arab Journal of Urology","volume":null,"pages":null},"PeriodicalIF":1.3000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10325112/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Arab Journal of Urology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/2090598X.2022.2138891","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Urosepsis is one of the most serious complications of percutaneous nephrolithotomy (PCNL). To date, many studies aim to prescreen urosepsis possibility after PCNL through blood components. This meta-analysis aims to determine C-reactive protein (CRP), neutrophil to lymphocyte ratio (NLR), and platelet to lymphocyte ratio (PLR) obtained preoperatively used to predict postoperative sepsis after PCNL.

Methods: A comprehensive literature search was performed through the electronic databases in March 2022. The quality of the included studies was assessed with Newcastle Ottawa Scale (NOS), while the presence of publication bias was assessed using Begg's and Egger's tests. Quantitative analysis was performed using RevMan 5.4 and Comprehensive Meta-Analysis 3.0. The outcome of interest is the difference in blood component count between groups that experienced systemic inflammatory response syndrome (SIRS) and those who did not. Acquired data were pooled as mean difference (MD).

Results: Total of 11 studies were included in the quantitative analysis. Leukocyte count showed an increase between the group that experienced SIRS and those who were not (MD 0.69, 95% confidence interval [CI] 0.48 to 0.91, p < 0.00001). Similar result was also found in other analysis, CRP (MD 3.30, 95% [CI] 2.33 to 4.26, p < 0.00001), NLR (MD 0.59, 95% [CI] 0.48 to 0.69, p < 0.00001), and PLR (MD 23.40, 95% [CI] 17.98 to 28.82, p < 0.00001).

Conclusion: Preoperative PLR, NLR, and CRP had significant association with postoperative sepsis after PCNL. It is beneficial for urologists to ensure close monitoring of these biomarkers levels before PCNL. The result of this study might serve as a consideration for future clinical approaches in determining beneficial treatment for urolithiasis patients.

Abstract Image

Abstract Image

Abstract Image

术前炎症生物标志物分析对经皮肾镜取石术后全身炎症反应综合征预后的影响:一项系统综述和荟萃分析。
尿脓毒症是经皮肾镜取石术(PCNL)最严重的并发症之一。迄今为止,许多研究旨在通过血液成分预先筛选PCNL后尿脓毒症的可能性。本荟萃分析旨在确定术前获得的c反应蛋白(CRP)、中性粒细胞与淋巴细胞比值(NLR)和血小板与淋巴细胞比值(PLR)用于预测PCNL术后脓毒症。方法:于2022年3月通过电子数据库进行全面的文献检索。纳入研究的质量采用Newcastle Ottawa Scale (NOS)进行评估,发表偏倚的存在采用Begg’s和Egger’s检验进行评估。采用RevMan 5.4和Comprehensive Meta-Analysis 3.0进行定量分析。感兴趣的结果是经历系统性炎症反应综合征(SIRS)的组与未经历系统性炎症反应综合征的组之间血液成分计数的差异。所得数据合并为平均差(MD)。结果:共纳入11项研究进行定量分析。白细胞计数在经历SIRS的组和未经历SIRS的组之间有所增加(MD = 0.69, 95%可信区间[CI] 0.48 ~ 0.91, p p p p)。结论:术前PLR、NLR和CRP与PCNL术后脓毒症有显著相关性。泌尿科医生在PCNL前密切监测这些生物标志物水平是有益的。本研究的结果可能为未来确定尿石症患者有益治疗的临床方法提供参考。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Arab Journal of Urology
Arab Journal of Urology UROLOGY & NEPHROLOGY-
CiteScore
2.80
自引率
0.00%
发文量
40
期刊介绍: The Arab Journal of Urology is a peer-reviewed journal that strives to provide a high standard of research and clinical material to the widest possible urological community worldwide. The journal encompasses all aspects of urology including: urological oncology, urological reconstructive surgery, urodynamics, female urology, pediatric urology, endourology, transplantation, erectile dysfunction, and urinary infections and inflammations. The journal provides reviews, original articles, editorials, surgical techniques, cases reports and correspondence. Urologists, oncologists, pathologists, radiologists and scientists are invited to submit their contributions to make the Arab Journal of Urology a viable international forum for the practical, timely and state-of-the-art clinical urology and basic urological research.
文献相关原料
公司名称 产品信息 采购帮参考价格
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信